Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 1.82 | -1.09% | -0.02 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Historical AMPE trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Crossed Above 50 DMA | Bullish | -1.09% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -1.09% | |
Outside Day | Range Expansion | -1.09% | |
Fell Below 50 DMA | Bearish | 1.68% | |
Narrow Range Bar | Range Contraction | 1.68% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 3% | 2 days ago |
Fell Below 50 DMA | 2 days ago |
50 DMA Support | 2 days ago |
Down 2 % | 2 days ago |
Down 1% | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 05/04/2021
Ampio Pharmaceuticals, Inc. Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Clinical Development Eye Diabetes Autoimmune Diseases Inflammation Autoimmune Disease Healthcare Facilities Dysfunction Kidney Disease Diagnostic Products Kidney Diseases Diabetic Retinopathy Macular Edema Eye Disease Diabetic Macular Edema Diabetic Nephropathy Metabolic Disorders Antioxidant Eye Diseases Methylphenidate Inflammatory Conditions Inflammation Diseases Male Sexual Dysfunction Sexual Dysfunction
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.98 |
52 Week Low | 0.45 |
Average Volume | 3,114,873 |
200-Day Moving Average | 1.21 |
50-Day Moving Average | 1.80 |
20-Day Moving Average | 1.75 |
10-Day Moving Average | 1.75 |
Average True Range | 0.15 |
ADX | 13.63 |
+DI | 21.22 |
-DI | 15.76 |
Chandelier Exit (Long, 3 ATRs ) | 1.70 |
Chandelier Exit (Short, 3 ATRs ) | 1.92 |
Upper Bollinger Band | 1.93 |
Lower Bollinger Band | 1.58 |
Percent B (%b) | 0.69 |
BandWidth | 20.13 |
MACD Line | 0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0184 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.96 | ||||
Resistance 3 (R3) | 1.95 | 1.90 | 1.93 | ||
Resistance 2 (R2) | 1.90 | 1.87 | 1.90 | 1.92 | |
Resistance 1 (R1) | 1.86 | 1.84 | 1.87 | 1.87 | 1.92 |
Pivot Point | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 |
Support 1 (S1) | 1.77 | 1.78 | 1.78 | 1.78 | 1.72 |
Support 2 (S2) | 1.72 | 1.75 | 1.72 | 1.72 | |
Support 3 (S3) | 1.68 | 1.72 | 1.71 | ||
Support 4 (S4) | 1.69 |